全文获取类型
收费全文 | 1722篇 |
免费 | 132篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 39篇 |
妇产科学 | 2篇 |
基础医学 | 139篇 |
临床医学 | 144篇 |
内科学 | 1005篇 |
皮肤病学 | 7篇 |
神经病学 | 4篇 |
特种医学 | 43篇 |
外科学 | 248篇 |
综合类 | 198篇 |
现状与发展 | 1篇 |
预防医学 | 24篇 |
药学 | 70篇 |
中国医学 | 18篇 |
肿瘤学 | 24篇 |
出版年
2024年 | 3篇 |
2023年 | 59篇 |
2022年 | 86篇 |
2021年 | 97篇 |
2020年 | 107篇 |
2019年 | 95篇 |
2018年 | 81篇 |
2017年 | 63篇 |
2016年 | 76篇 |
2015年 | 58篇 |
2014年 | 86篇 |
2013年 | 115篇 |
2012年 | 77篇 |
2011年 | 93篇 |
2010年 | 61篇 |
2009年 | 60篇 |
2008年 | 79篇 |
2007年 | 73篇 |
2006年 | 63篇 |
2005年 | 72篇 |
2004年 | 53篇 |
2003年 | 50篇 |
2002年 | 37篇 |
2001年 | 34篇 |
2000年 | 33篇 |
1999年 | 31篇 |
1998年 | 26篇 |
1997年 | 21篇 |
1996年 | 34篇 |
1995年 | 17篇 |
1994年 | 27篇 |
1993年 | 17篇 |
1992年 | 14篇 |
1991年 | 9篇 |
1990年 | 8篇 |
1989年 | 7篇 |
1988年 | 15篇 |
1987年 | 6篇 |
1986年 | 3篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1979年 | 2篇 |
排序方式: 共有1968条查询结果,搜索用时 15 毫秒
101.
102.
目的 比较自身免疫性肝炎(AIH)合并原发性胆汁性胆管炎(PBC)或部分肝外自身免疫性疾病(autoimmune disease)患者与单纯AIH患者临床特点及并发症,为改善AIH患者的诊治提供参考。方法 收集1999年8月~2019年8月我院收治的AIH患者149例,根据合并症分为无合并病的AIH组(68例)、AIH合并PBC组(AIH-PBC 组,41例)及AIH合并肝外自身免疫性疾病组(AIH-肝外组,40例),比较三组临床特点、并发症、肝纤维化/肝硬化进展情况。结果 ①AIH-PBC 组及AIH-肝外组年龄低于AIH组,差异有统计学意义(P<0.05);三组性别比较,差异无统计学意义(P>0.05)。②三组共有的临床症状为瘙痒、黄疸、乏力、食欲不振及腹部不适,其中AIH-PBC组瘙痒症状患者多于AIH组、AIH-肝外组,差异有统计学意义(P<0.05);三组黄疸、乏力、食欲不振及腹部不适比较,差异无统计学意义(P>0.05)。③AIH-PBC 组ALT低于AIH组及AIH-肝外组,ALP、GGT高于AIH组及AIH-肝外组,差异有统计学意义(P<0.05);AIH-肝外组的AST、DBIL高于AIH组及AIH-PBC 组,差异有统计学意义(P<0.05);AIH-肝外组IgG水平高于AIH组及AIH-PBC 组,差异有统计学意义(P<0.05)。④三组ANA、ASMA、SLA、LKM-1阳性率比较,差异无统计学意义(P>0.05);AIH-PBC组AMA、AMA-M2 阳性率高于AIH组、AIH-肝外组,差异有统计学意义(P<0.05)。⑤三组均以界面性肝炎和淋巴细胞浸润表现居多,其中AIH-PBC组胆管病变、胆汁淤积高于AIH组,差异有统计学意义(P<0.05)。⑥三组并发症主要包括食管胃底静脉曲张/破裂出血、腹水、肝性脑病、肝癌、肝移植,组间比较,差异无统计学意义(P>0.05)。⑦三组肝纤维化/肝硬化发生率比较,差异无统计学意义(P>0.05);但AIH-PBC组2~5年肝纤维化/肝硬化进展率高于AIH组及AIH-肝外组,差异有统计学意义(P<0.05)。结论 合并PBC的AIH患者比单纯AIH患者诊断年龄早,肝脏炎症反应轻、胆管病变重;比AIH及合并肝外自身免疫性疾病更易出现瘙痒、胆汁淤积更重、胆管损伤更严重,且肝纤维化/肝硬化速度更快。AMA、AMA-M2可作为AIH合并PBC的鉴别指标。另外,AIH合并肝外自身免疫性疾病常存在肝功能损害,IgG对其具有提示意义。 相似文献
103.
A. Ahmad R. Heijke P. Eriksson L. Wirestam S. Kechagias C. Dahle C. Sjwall 《Clinical and experimental immunology》2021,203(1):22-31
Knowledge of concomitant autoimmune liver diseases (AILD) is more detailed in primary Sjögren’s syndrome (pSS) compared to systemic lupus erythematosus (SLE). Herein, the prevalence of autoantibodies associated with autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) was investigated in stored sera from patients with SLE (n = 280) and pSS (n = 114). Antibodies against mitochondria (AMA), liver–kidney microsomal (LKM) antigen, smooth muscle (SMA) and anti‐nuclear antibodies (ANA) were analysed with immunofluorescence microscopy. In addition, AILD‐associated autoantibodies were tested with immunoblot. Prior to sampling, eight SLE (2·9%) and three pSS (2·6%) cases were diagnosed with AILD. Among SLE‐cases without known AILD (n = 272), 26 (9·6%) had PBC‐associated autoantibodies, 15 (5·5%) AIH‐associated autoantibodies (excluding ANA) and one serological overlap. Most subjects with PBC‐associated autoantibodies had liver enzymes within reference limits (22 of 27, 81%) or mild laboratory cholestasis (two of 27, 7·4%), while one fulfilled the diagnostic PBC‐criteria. AMA‐M2 detected by immunoblot was the most common PBC‐associated autoantibody in SLE (20 of 272, 7·4%). The prevalence of SMA (4·4%) was comparable with a healthy reference population, but associated with elevated liver enzymes in four of 12 (25%), none meeting AIH‐criteria. The patient with combined AIH/PBC‐serology had liver enzymes within reference limits. Among pSS cases without known AILD (n = 111), nine (8·1%) had PBC‐associated, 12 (10·8%) AIH‐associated autoantibodies and two overlapped. PBC‐associated autoantibodies were found as frequently in SLE as in pSS but were, with few exceptions, not associated with laboratory signs of liver disease. Overall, AILD‐associated autoantibodies were predominantly detected by immunoblot and no significant difference in liver enzymes was found between AILD autoantibody‐negative and ‐positive patients. 相似文献
104.
Tae-Hyeon Kim Jong Ho Moon Christopher E Savard Rahul Kuver Sum P Lee 《Journal of gastroenterology and hepatology》2009,24(7):1218-1225
Background and Aim: Little is known about the role of platelet-derived growth factor (PDGF) in biliary fibrosis in the setting of bacterial colonization of the biliary tree. We therefore sought to investigate whether exposure to bacterial lipopolysaccharide (LPS) alters PDGF isoform and receptor expression in cultured rat common bile duct fibroblasts (CBDF) and normal rat cholangiocytes (NRC).
Methods: Collagen content in cells and media was assessed by colorimetric assay and gel electrophoresis. mRNA levels of PDGF-A and -B, and PDGF-Receptors (PDGF-R) α and β were measured by relative quantitative real-time PCR. Protein levels of PDGF-AA, AB and BB were measured by ELISA, and PDGF-Rα and PDGF-Rβ by Western blot.
Results: In CBDF, LPS increased total soluble collagen synthesis and secretion. PDGF-Rα and β mRNA and protein were also increased by LPS treatment in CBDF. Lipopolysaccharide treatment elicited an increase in PDGF-A and -B mRNA levels in CBDF. In NRC, levels of PDGF-A mRNA increased in a dose-dependent fashion following LPS treatment, whereas PDGF-B mRNA showed no response. PDGF-AA secretion was higher by CBDF than by NRC. PDGF-BB levels were also higher in CBDF than in NRC. While PDGF-BB levels did not respond to LPS treatment in CBDF, there was a dose-dependent response of this isoform to LPS in NRC. Intracellular and secreted PDGF-AB increased with LPS treatment in NRC.
Conclusions: These results support a model in which chronic bacterial colonization of the biliary tree induces fibrosis through PDGF-dependent mechanisms. 相似文献
Methods: Collagen content in cells and media was assessed by colorimetric assay and gel electrophoresis. mRNA levels of PDGF-A and -B, and PDGF-Receptors (PDGF-R) α and β were measured by relative quantitative real-time PCR. Protein levels of PDGF-AA, AB and BB were measured by ELISA, and PDGF-Rα and PDGF-Rβ by Western blot.
Results: In CBDF, LPS increased total soluble collagen synthesis and secretion. PDGF-Rα and β mRNA and protein were also increased by LPS treatment in CBDF. Lipopolysaccharide treatment elicited an increase in PDGF-A and -B mRNA levels in CBDF. In NRC, levels of PDGF-A mRNA increased in a dose-dependent fashion following LPS treatment, whereas PDGF-B mRNA showed no response. PDGF-AA secretion was higher by CBDF than by NRC. PDGF-BB levels were also higher in CBDF than in NRC. While PDGF-BB levels did not respond to LPS treatment in CBDF, there was a dose-dependent response of this isoform to LPS in NRC. Intracellular and secreted PDGF-AB increased with LPS treatment in NRC.
Conclusions: These results support a model in which chronic bacterial colonization of the biliary tree induces fibrosis through PDGF-dependent mechanisms. 相似文献
105.
Vogel A Wedemeyer H Manns MP Strassburg CP 《Journal of gastroenterology and hepatology》2002,17(Z3):S389-S398
Autoimmune hepatitis is a well-established chronic liver disease. It primarily affects women, is characterized by circulating autoantibodies and elevated gammaglobulins and is associated with extrahepatic immune-mediated syndromes. Treatment regimens have remained unchanged for a number of years because of the high efficacy of steroid monotherapy, or combination therapy of azathioprine and steroids. In approximately 90% of patients remission of the disease is reached by medical therapy, which is usually administered lifelong because long-term remission after drug withdrawal is achieved in only 17% of patients. In 10% of patients treatment failure is observed. The challenge of remission induction involves the use of transplant immunosuppressants such as cyclosporine, mycophenolate moffetil, and tacrolimus. The challenge of maintenance therapy minimizing steroid side-effects involves the evaluation of topical steroids and the use of azathioprine monotherapy. Overlap syndromes occur in approximately 20% of autoimmune liver diseases. The diagnosis is broadly based on serological, biochemical, clinical and histological parameters. Most common are the overlap of autoimmune hepatitis and primary biliary cirrhosis, as well as autoimmune hepatitis with primary sclerosing cholangitis. These yet incompletely defined syndromes are an important differential diagnosis in the difficult-to-treat patient with autoimmune hepatitis. 相似文献
106.
Bastian Engel Richard Taubert Elmar Jaeckel Michael P. Manns 《Liver international》2020,40(Z1):149-153
Autoimmune liver diseases (AILD), namely autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), are rare diseases. These days, patients with PBC almost never require liver transplantation. When treated early with ursodeoxycholic acid patients have a normal life expectancy if the disease is diagnosed at an early stage and the patients respond to treatment. Patients with AIH often go into remission with first‐line therapy including corticosteroids alone or in combination with azathioprine. Nevertheless, about one quarter of patients already developed cirrhosis at diagnosis. Those who do not respond to first line standard of care (SOC) have significant liver‐related morbidity and mortality. No approved second‐ or third‐line treatments are available and the drugs are selected based on limited case series and personal experience. Larger trials are needed to develop efficient therapies for difficult‐to‐treat AIH patients. No treatment has been found to alter the natural course of disease in patients with PSC except for liver transplantation. Identifying PSC patients at risk of developing cholangiocarcinoma (CCA) is another unmet need. Current research in all AILD including AIH, PBC and PSC, focuses on improving our understanding of the underlying disease process and identifying new therapeutic targets to decrease morbidity and mortality. 相似文献
107.
Aristeidis Grigoriadis Fabian Morsbach Nikolaos Voulgarakis Karouk Said Annika Bergquist Nikolaos Kartalis 《Scandinavian journal of gastroenterology》2020,55(2):228-235
AbstractObjectives: Interpretation of MRI/MRCP in primary sclerosing cholangitis (PSC) at a single time point has low inter-reader agreement. Agreement of interpretation of the dynamic course of duct changes in follow-up MRI/MRCP is of clinical importance but remains unknown. Our aims are therefore to assess the inter-reader agreement of interpretation of the course of duct changes in PSC and investigate if elimination of 3?D MRCP affects inter-reader agreement.Materials and Methods: We studied 40 consecutive PSC-patients who underwent two liver MRI/MRCPs at two time points. Two readers independently evaluated the course of duct changes between the two time points in two imaging sets, one with and one without 3?D MRCP. The intraclass correlation coefficient (ICC) was calculated for evaluation of inter-reader and intra-reader agreement between the two time points and two imaging sets accordingly.Results: Inter-reader agreement of the interpretation of the course of duct changes between the two time points was poor (ICC up to 0.224). Elimination of 3?D MRCP neither improved inter-reader agreement which was again poor (ICC up to 0.26) nor did it change considerably the way readers interpret the course of ducts changes (ICC for intra-reader agreement between 0.809 and 0.978).Conclusions: Inter-reader agreement of the interpretation of radiological course of duct changes is poor in serial follow-up MRI/MRCP of PSC-patients. Elimination of 3?D MRCP does not increase inter-reader agreement but maintains an excellent intra-reader agreement for the interpretation of the dynamic course of bile duct changes.
- Key points
Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up MRI/MRCP examinations of patients with PSC is poor.
Absence of 3D MRCP does not affect considerably the way readers interpret the radiological course of bile ducts changes.
When MRCP is absent or of low quality, utilization of other sequences seems to be helpful as an alternative for bile duct evaluation.
108.
目的 探讨熊去氧胆酸(UDCA)联合非诺贝特治疗原发性胆汁性胆管炎(PBC)患者血清转化生长因子-β(TGF-β)、γ-干扰素(IFN-γ)和白介素-10(IL-10)水平的变化。方法 2016年12月~2018年12月我科诊治PBC患者48例,随机将患者分为观察组(n=24)和对照组(n=24)。给予对照组患者UDCA治疗半年,给予观察组UDCA联合非诺贝特口服治疗半年。采用ELISA法检测血清TGF-β、IFN-γ和IL-10水平。使用FibroTouch行肝脏硬度测定(liver stiffness measurement, LSM)。结果 在治疗观察结束时,观察组血清谷丙转氨酶水平为(51.4±23.7)U/L,显著低于对照组【(74.9±21.2)U/L,P<0.05】,谷草转氨酶为(59.5±32.3)U/L,显著低于对照组【(81.3±35.8)U/L,P<0.05】,谷氨酰转肽酶水平为(95.7±31.8)U/L,显著低于对照组【(127.3±50.7)U/L,P<0.05】;观察组血清IFN-γ水平为(57.4±21.3)pg/mL,显著高于对照组【(39.7±23.7)pg/mL,P<0.05】,而血清TGF-β水平为(14.3±4.8)pg/mL,显著低于对照组【(23.6±3.5)pg/mL,P<0.05】;观察组血清免疫球蛋M(IgM)为(2.3±0.4)g/L,显著低于对照组【(3.1±0.9)g/L,P<0.05】, IgG水平为(11.3±1.8)g/L,显著低于对照组【(15.5±1.3)g/L,P<0.05】,IgA水平为(2.7±0.6)g/L,显著低于对照组【(3.5±0.2)g/L,P<0.05】;观察组患者LSM为(10.8±6.5)kPa,与对照组的(9.7±7.7)kPa比,无统计学差异(P>0.05)。结论 熊去氧胆酸联合非诺贝特联合治疗PBC患者可以明显改善血生化指标,可能与抑制了免疫球蛋白水平和提高了血清IFN-γ水平有关,其治疗的远期疗效还有待于观察。 相似文献
109.
110.
Patients suffering from primary sclerosing cholangitis (PSC) show considerable differences regarding clinical manifestations (i.e. large duct versus small-duct PSC, presence or absence of concomitant inflammatory bowel disease), disease progression, risk for malignancy and response to therapy, raising the question whether PSC may represent a mixed bag of diseases of different aetiologies. The growing list of secondary causes and diseases 'mimicking' or even overlapping with PSC (e.g. IgG4-associated sclerosing cholangitis), which frequently causes problems in clear-cut discrimination from classic PSC and the emerging knowledge about potential disease modifier genes (e.g. variants of CFTR, TGR5 and MDR3) support such a conceptual view. In addition, PSC in children differs significantly from PSC in adults in several aspects resulting in distinct therapeutic concepts. From a clinical perspective, appropriate categorization and careful differential diagnosis are essential for the management of concerned patients. Therefore, the aim of the current review is to summarize current and evolving pathophysiological concepts and to provide up-to-date perspectives including future treatment strategies for PSC. 相似文献